|
DE2059922A1
(de)
*
|
1970-12-05 |
1972-06-15 |
Boehringer Mannheim Gmbh |
Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben
|
|
DE2157036A1
(de)
*
|
1971-11-17 |
1973-05-24 |
Boehringer Mannheim Gmbh |
Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
|
|
US3966916A
(en)
*
|
1972-09-09 |
1976-06-29 |
Boehringer Mannheim G.M.B.H. |
N(6)-disubstituted adenoisine compounds and therapeutic compositions
|
|
US3931401A
(en)
*
|
1972-10-21 |
1976-01-06 |
Abbott Laboratories |
1,N6 -etheno-5'-adenosine carboxamides for increasing coronary sinus partial pressure of oxygen
|
|
DE2338705A1
(de)
*
|
1973-07-31 |
1975-02-13 |
Boehringer Mannheim Gmbh |
Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
|
|
DE2541342A1
(de)
*
|
1975-09-17 |
1977-03-31 |
Boehringer Mannheim Gmbh |
Neue phenoxyalkylcarbonsaeuren und verfahren zur herstellung derselben
|
|
DE3019322A1
(de)
*
|
1980-05-21 |
1981-12-03 |
Merck Patent Gmbh, 6100 Darmstadt |
Psychopharmakon sowie verwendung von adenosinderivaten
|
|
US4495180A
(en)
*
|
1982-06-21 |
1985-01-22 |
Merck & Co., Inc. |
Prodrugs of Ara-A an antiviral agent
|
|
US4657897A
(en)
*
|
1984-06-22 |
1987-04-14 |
Warner-Lambert Company |
N6 -substituted adenosines for treating pain
|
|
US4593019A
(en)
*
|
1984-10-26 |
1986-06-03 |
Warner-Lambert Company |
N6 -tricyclic adenosines
|
|
US4663313A
(en)
*
|
1984-10-26 |
1987-05-05 |
Warner-Lambert Company |
N6 -tricyclic adenosines for treating hypertension
|
|
US5284834A
(en)
*
|
1985-03-29 |
1994-02-08 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
|
|
HU198950B
(en)
*
|
1986-12-15 |
1989-12-28 |
Sandoz Ag |
Process for producing new furanuronic acid derivatives and pharmaceutical compositions comprising such compounds
|
|
FR2663936A1
(fr)
*
|
1987-12-23 |
1992-01-03 |
Glaxo Group Ltd |
Derives de l'adenosine, leur procede de preparation et leur utilisation en therapeutique.
|
|
GB8729994D0
(en)
*
|
1987-12-23 |
1988-02-03 |
Glaxo Group Ltd |
Chemical compounds
|
|
US5030624A
(en)
*
|
1988-10-26 |
1991-07-09 |
G. D. Searle & Co. |
R-diastereomer of an N6 -[(2-hydroxypropyl)aryl]adenosine and its medicinal uses
|
|
US5032584A
(en)
*
|
1988-10-26 |
1991-07-16 |
G. D. Searle & Co. |
S-diastereomer of an n6 -((2-hydroxypropyl)aryl)adenosine and its medicinal uses
|
|
US5055569A
(en)
*
|
1989-10-19 |
1991-10-08 |
G. D. Searle & Co. |
N-(6)-substituted adenosine compounds
|
|
DK62692D0
(pl)
*
|
1992-05-14 |
1992-05-14 |
Novo Nordisk As |
|
|
US5672588A
(en)
*
|
1992-05-20 |
1997-09-30 |
Novo Nordisk A/S |
Purine derivatives
|
|
EP0708781B1
(en)
*
|
1993-07-13 |
2001-10-04 |
THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services |
A 3 adenosine receptor agonists
|
|
WO1997037667A1
(en)
|
1996-04-10 |
1997-10-16 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
|
|
US5998386A
(en)
*
|
1997-09-19 |
1999-12-07 |
Feldman; Arthur M. |
Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue
|
|
AU3540101A
(en)
*
|
2000-01-07 |
2001-07-16 |
Universitaire Instelling Antwerpen |
Purine derivatives, process for their preparation and use thereof
|
|
CZ294538B6
(cs)
*
|
2002-12-30 |
2005-01-12 |
Ústav Experimentální Botaniky Akademie Vědčeské Re |
Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
|
EP3527571A1
(en)
*
|
2018-02-14 |
2019-08-21 |
Université de Liège |
Pyrimidine derivatives for prevention and treatment of bacterial infection
|